孕期糖尿病妇女的产后身体活动干预:一个随机对照试验
Caroline A Racke1, Sarah A Keim1,2,3, Samrawit F Yisahak1,2
1Center for Biobehavioral Health, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
American journal of lifestyle medicine
|June 19, 2025
概括
在产后佩戴脚重量并没有显著影响妊娠糖尿病 (GDM) 妇女的体重,体脂或生物标志物. 这种干预措施在GDM患者产后康复的标准护理中没有显示任何额外的益处.
科学领域:
- 生殖健康和内分泌学
- 代谢和心血管健康
- 临床试验和干预研究研究.
背景情况:
- 孕期糖尿病 (GDM) 增加了母亲和婴儿健康并发症的风险.
- 产后康复和代谢健康对于有经历GDM的女性至关重要.
- 需要基于证据的干预措施来改善GDM患者的产后结果.
研究的目的:
- 评估GDM产后妇女在日常活动中佩戴脚重量的有效性.
- 评估脚重量对体重,身体组成和关键生物标志物的影响.
- 为了比较脚重量干预组和标准护理对照组之间的结果.
主要方法:
- 一个平行的双臂,随机对照试验 (RCT) 涉及产后妇女有史以来的GDM.
- 干预组在产后25-35天至190-210天每天2小时佩戴1.1公斤的脚重量.
- 主要结局:身体重量. 二次结果:身体组成,血糖,脂质和炎症生物标志物. 使用线性混合模型进行分析.
主要成果:
- 没有观察到体重变化 (ANK:3.8 kg vs. CTRL:2.2 kg) 或体脂百分比变化中的显著差异.
- 两组都显示了总胆固醇的降低,没有与干预有关的显著差异.
- 与标准护理相比,脚重量干预没有在其他次要结果中显著改善.
结论:
- 在每日产后活动中佩戴脚重量并没有显著改善GDM妇女的体重,组成或代谢生物标志物.
- 与该人群的标准产后护理相比,该干预措施没有显示任何额外的益处.
- 进一步的研究可能会探索产后GDM管理的不同体力活动干预措施或持续时间.
更多相关视频
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
12.7K
05:17Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
Published on: April 5, 2024
923
相关概念视频
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Dipeptidyl Peptidase 4 Inhibitors
271
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
271
Peripheral Artery Disease V: Postoperative Nursing Management
28
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
28
